EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Diabetic Ketoacidosis: Brain Morphology and Cognition

Completed

Conditions: Diabetic Ketoacidosis

First Posted Date: 2015-05-13

Last Posted Date: 2017-10-25

Lead Sponsor: Emory University

Target Recruit Count: 45

Registration Number: NCT02443415

Locations: 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

Improving Survey Procedures for Young Men Who Have Sex With Men in Web-based HIV Prevention: Retention Study

Not Applicable

Completed

Conditions: Healthy

Interventions: Behavioral: Altruistic Incentive
Behavioral: Dashboard Incentive
Behavioral: Monetary Incentive

First Posted Date: 2015-04-23

Last Posted Date: 2016-05-09

Lead Sponsor: Emory University

Target Recruit Count: 1131

Registration Number: NCT02424643

Locations: 🇺🇸
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States

Comparative Autoantibody and Immunologic Cell Marker Study

Conditions: Communicable Diseases
Autoimmune Diseases
Lupus Erythematosus, Systemic

First Posted Date: 2015-04-21

Last Posted Date: 2024-08-19

Lead Sponsor: Emory University

Target Recruit Count: 2500

Registration Number: NCT02422875

Locations: 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States

Inflammation-Induced CNS Glutamate During Breast Cancer Treatment

Completed

Conditions: Breast Cancer

First Posted Date: 2015-04-21

Last Posted Date: 2019-08-01

Lead Sponsor: Emory University

Target Recruit Count: 98

Registration Number: NCT02421978

Locations: 🇺🇸
Emory University Department of Psychiatry and Behavioral Sciences, Atlanta, Georgia, United States

High-Shear Microfluidic Thrombosis Assay

Completed

Conditions: Coagulation Defects, Other and Unspecified

First Posted Date: 2015-04-21

Last Posted Date: 2018-06-07

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT02422810

Locations: 🇺🇸
Emory Clinic, Atlanta, Georgia, United States

Sympatholysis in Chronic Kidney Disease

Phase 1

Recruiting

Conditions: Chronic Kidney Disease

Interventions: Drug: Sodium Bicarbonate
Drug: Placebo
Behavioral: Exercise Training
Behavioral: Control to Exercise (Stretching)

First Posted Date: 2015-04-08

Last Posted Date: 2023-09-13

Lead Sponsor: Emory University

Target Recruit Count: 110

Registration Number: NCT02411773

Locations: 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States

Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

Phase 4

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Insulin glargine
Drug: Insulin aspart
Drug: Supplemental insulin aspart

First Posted Date: 2015-04-03

Last Posted Date: 2023-09-28

Lead Sponsor: Emory University

Target Recruit Count: 226

Registration Number: NCT02408120

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)

Not Applicable

Completed

Conditions: Hypertension
Diabetes

Interventions: Drug: Placebo
Drug: Salsalate
Drug: Carvedilol
Drug: Intralipid 20%

First Posted Date: 2015-04-02

Last Posted Date: 2019-01-08

Lead Sponsor: Emory University

Target Recruit Count: 36

Registration Number: NCT02406586

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Cardiac Output Monitoring in Burn Patients

Not Applicable

Withdrawn

Conditions: Burns

Interventions: Device: NICOM (non-invasive cardiac output monitor)

First Posted Date: 2015-03-31

Last Posted Date: 2018-02-28

Lead Sponsor: Emory University

Registration Number: NCT02404597

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV

Phase 4

Completed

Conditions: HIV

Interventions: Drug: Truvada
Device: Gel lubricant

First Posted Date: 2015-03-27

Last Posted Date: 2018-02-19

Lead Sponsor: Emory University

Target Recruit Count: 86

Registration Number: NCT02401230

Locations: 🇺🇸
The Hope Clinic of of Emory University, Decatur, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy